AQP4 and neuromyelitis optica: Autoantibodies directed to AQP4 are at the basis of the pathogenesis of neuromyelitis optica (NMO), an inflammatory CNS disorder characterized by astrocyte loss, axonal damage and demyelination (21–23), while the occurrence of anti-Kir 4.1 antibodies in MS is controversial (24).